Cargando…

COVID-19 vaccine preferences in India()

India’s mass vaccination efforts have been slow due to high levels of vaccine hesitancy. This study uses data from an online discrete choice experiment with 1371 respondents to rigorously examine the factors shaping vaccine preference in the country. We find that vaccine efficacy, presence of side e...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, Prateek, Raj, Alok, Mani Shukla, Dhirendra, Sunder, Naveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898737/
https://www.ncbi.nlm.nih.gov/pubmed/35282928
http://dx.doi.org/10.1016/j.vaccine.2022.02.077
_version_ 1784663724892618752
author Bansal, Prateek
Raj, Alok
Mani Shukla, Dhirendra
Sunder, Naveen
author_facet Bansal, Prateek
Raj, Alok
Mani Shukla, Dhirendra
Sunder, Naveen
author_sort Bansal, Prateek
collection PubMed
description India’s mass vaccination efforts have been slow due to high levels of vaccine hesitancy. This study uses data from an online discrete choice experiment with 1371 respondents to rigorously examine the factors shaping vaccine preference in the country. We find that vaccine efficacy, presence of side effects, protection duration, distance to vaccination centre and vaccination rates within social network play a critical role in determining vaccine demand. We apply a non-parametric model to uncover heterogeneity in the effects of these factors. We derive two novel insights from this analysis. First, even though, on average, domestically developed vaccines are preferred, around 30% of the sample favours foreign-developed vaccines. Second, vaccine preference of around 15% of the sample is highly sensitive to the presence of side effects and vaccination uptake among their peer group. These results provide insights for the ongoing policy debate around vaccine adoption in India.
format Online
Article
Text
id pubmed-8898737
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-88987372022-03-07 COVID-19 vaccine preferences in India() Bansal, Prateek Raj, Alok Mani Shukla, Dhirendra Sunder, Naveen Vaccine Short Communication India’s mass vaccination efforts have been slow due to high levels of vaccine hesitancy. This study uses data from an online discrete choice experiment with 1371 respondents to rigorously examine the factors shaping vaccine preference in the country. We find that vaccine efficacy, presence of side effects, protection duration, distance to vaccination centre and vaccination rates within social network play a critical role in determining vaccine demand. We apply a non-parametric model to uncover heterogeneity in the effects of these factors. We derive two novel insights from this analysis. First, even though, on average, domestically developed vaccines are preferred, around 30% of the sample favours foreign-developed vaccines. Second, vaccine preference of around 15% of the sample is highly sensitive to the presence of side effects and vaccination uptake among their peer group. These results provide insights for the ongoing policy debate around vaccine adoption in India. Elsevier Ltd. 2022-04-01 2022-03-07 /pmc/articles/PMC8898737/ /pubmed/35282928 http://dx.doi.org/10.1016/j.vaccine.2022.02.077 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Bansal, Prateek
Raj, Alok
Mani Shukla, Dhirendra
Sunder, Naveen
COVID-19 vaccine preferences in India()
title COVID-19 vaccine preferences in India()
title_full COVID-19 vaccine preferences in India()
title_fullStr COVID-19 vaccine preferences in India()
title_full_unstemmed COVID-19 vaccine preferences in India()
title_short COVID-19 vaccine preferences in India()
title_sort covid-19 vaccine preferences in india()
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898737/
https://www.ncbi.nlm.nih.gov/pubmed/35282928
http://dx.doi.org/10.1016/j.vaccine.2022.02.077
work_keys_str_mv AT bansalprateek covid19vaccinepreferencesinindia
AT rajalok covid19vaccinepreferencesinindia
AT manishukladhirendra covid19vaccinepreferencesinindia
AT sundernaveen covid19vaccinepreferencesinindia